Abstract
Despite many advances since Gibbon’s first cardiopulmonary bypass (CPB) in 1953, end-organ damage and neurologic dysfunction remain a challenge in the management of pediatric patients undergoing cardiac surgery. A comprehensive understanding of the inflammatory process caused by CPB has led to intraoperative strategies that intend to minimize such responses.
Exposure of blood to the CPB circuit induces a complex systemic inflammatory response (SIRS), which involves the activation of multiple, interdependent cellular and humoral pathways. The coagulation and complement pathways are activated when the plasmatic proteins are exposed to the circuit material. Once cellular activation occurs, released proinflammatory cytokines, adhesion molecules, and chemokines are responsible for the amplification of the inflammatory cascade.
Each of the inflammatory cascade components has an important role in a process that ultimately results in vascular injury and end-organ damage.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bronicki R, Hall M, Cardiopulmonary bypass-induced inflammatory response: pathophysiology and treatment. Pediatric Critical Care Medicine. 2016;17(8_suppl):S272-S278.
Gravlee G, Davis R, Stammers A, Ungerleider R. Cardiopulmonary Bypass. Philadelphia: Lippincott Williams & Wilkins; 2008
Kozik DJ, Tweddell JS. Characterizing the inflammatory response to cardiopulmonary bypass in children. Ann Thorac Surg. 2006;81(6):S2347–54. Review.
Wan S, LeClerc JL, Vincent JL. Inflammatory response to cardiopulmonary bypass mechanisms involved and possible therapeutic strategies. Chest. 1997;112:676–692.
Brix-Christensen V. The systemic inflammatory response after cardiac surgery with cardiopulmonary bypass in children. Acta Anaesthesiol Scand. 2001;45:671–667.
Madhok A, Viraga OK, Haridas V, Parnell V, Savita P. Cytokine response in children undergoing surgery for congenital heart disease. Pediatr Cardiol. 2006;27:408–413.
Chong A, Hampton CR, Edward D. Verrier microvascular inflammatory response in cardiac surgery. Semin Cardiothorac Vasc Anesth. 2003;7:333.
Hall RI. Cardiopulmonary bypass and the systemic inflammatory response: effects on drug action. J Cardiothorac Vasc Anesth. 2002;16:83–98.
Jaggers J, Lawson JH. Coagulopathy and inflammation in neonatal heart surgery: mechanisms and strategies. Ann Thorac Surg. 2006;81:S2360–S2366.
Cuccurullo L, Accardo M, Agozzino L, Blasi F, Esposito S, Vosa C. Ultrastructural pathology of pediatric myocardium in acute ischemia: bioptic study before and after treatment with cardioplegic solution. Ultrastruct Pathol. 2006;30:453–460.
Hsia TY, Gruber PJ. Factors influencing neurologic outcome after neonatal cardiopulmonary bypass: what we can and cannot control. Ann Thorac Surg. 2006;81:S2381–S2388.
Gaynor JW, Wernovsky G, Jarvik GP, Bernbaum J, Gerdes M, et al. Patient characteristics are important determinants of neurodevelopmental outcome at one year of age after neonatal and infant cardiac surgery. J Thorac Cardiovasc Surg. 2007;133:1344–1353.
Markowitz SD, Ichord RN, Wernovsky G, Gaynor JW, Nicolson SC. Surrogate markers for neurological outcome in children after deep hypothermic circulatory arrest. Semin Cardiothorac Vasc Anesth. 2007;11:59–65.
Matte G. Perfusion for Congenital Heart Surgery. Notes on Cardiopulmonary Bypass for a Complex Patient Population. Boston, MA: Wiley Blackwell; 2015
Durandy Y, Minimizing systemic inflammation during cardiopulmonary bypass in the pediatric population Artif Organs. 2014 Jan;38(1):11–8.
Pigula FA, Gandhi SK, Davis PJ, Webber SA, Nemato EM. Regional low-flow perfusion provides somatic circulatory support during neonatal aortic arch surgery. Ann Thorac Surg. 2001;72(2):406–407.
Wypij D, Newburger JW, Rappaport LA, duPlessis AJ, Jonas RA, Wernovsky G, Lin M, Bellinger DC. The effect of duration of deep hypothermic circulatory arrest in infant heart surgery on late neurodevelopment: the Boston Circulatory Arrest Trial. J Thorac Cardiovasc Surg. 2003 Nov;126(5):1397–403
Dahlbacka S, Alaoja H, Mäkelä J, Niemelä E, Laurila P, Kiviluoma K, Honkanen A, Ohtonen P, Anttila V, Juvonen T. Effects of pH management during selective antegrade cerebral perfusion on cerebral microcirculation and metabolism: alpha-stat versus pH-stat. Ann Thorac Surg. 2007; 84:847–855.
Halstead JC, Spielvogel D, Meier DM, et al. Optimal pH strategy for selective cerebral perfusion. Eur J Cardiothorac Surg. 2005;28:266–273.
Bellinger DC, Wypij D, AJ Du plessis, Rappaport LA, et al. Developmental and neurologic effects of alpha-stat versus pH-stat strategies for deep hypothermic cardiopulmonary bypass in infants. J Thorac Cardiovasc Surg. 2001;121:374–383.
Jonas RA, Wypij D, Roth SJ, et al. The influence of hemodilution on outcome after hypothermic cardiopulmonary bypass: results of a randomized trial in infants. J Thorac Cardiovasc Surg. 2003;126:1765–1774
Hensley F, Martin D, Gravlee G. A Practical Approach to Cardiac Anesthesia. Philadelphia, PA: Lippincott Williams & Wilkins; 2013.
Mongero L, Beck J. On Bypass: Advanced Perfusion Techniques. Totowa, NJ: Humana Press; 2008.
AmSECT. American Society of Extracorporeal Technology Standards and Guidelines for Perfusion Practice. 2017.
Boettcher W, Dehmel F, Redlin M, Miera O, Musci M, Cho M, Photiadis J. Complex cardiac surgery on patients with a body weight of less than 5 kg without donor blood transfusion. J Extra Corpor Technol. 2017;49:93–97
Ratliff T, Hodge A, Preston T, Galantowicz M, Naguib A, Gomez D. Bloodless pediatric cardiopulmonary bypass for a 3.2-kg patient whose parents are of Jehovah’s witness faith. J Extra Corpor Technol. 2014;46:173–176.
Olshove V, Berndsen N, Sivarajan V, Nawathe P, Phillips A. Comprehensive blood conservation program in a new congenital cardiac surgical program allows bloodless surgery for the Jehovah Witness and a reduction for all patients. Perfusion. 10/6/17: https://doi.org/10.1177/0267659117733810.
Kaplan J, Augoustides G, Manecke G, Maus T, Reich D. Kaplan’s Cardiac Anesthesia for Cardiac and Noncardiac Surgery. Philadelphia: Elsevier; 2017.
Rath T, Sutton R, Ploessl J. A comparison of static occlusion setting: fluid drop rate and pressure drop. J Extra Corpor Technol. 1996;28:21–26.
McRobb C, Mejak B, Ellis C, Lawson S, Twite M. Recent advances in pediatric cardiopulmonary bypass. Perfusion. 2014, Vol. 18(2) 153–160.
Jabur G, Sidhu K, Willcox T, Mitchell S. Clinical evaluation of emboli removal by integrated versus non-integrated arterial filters in new generation oxygenators. Perfusion. 2016, Vol. 31(5) 409–417.
Strother A,Wang S, Kunselman A, Ündar A. Handling ability of gaseous microemboli of two pediatric arterial filters in a simulated CPB model. Perfusion. 2013, 28(3) 244–252.
Potger K, McMillan D, Ambrose M. Air transmission comparison of the affinity fusion oxygenator with an integrated arterial filter to the affinity NT oxygenator with a separate arterial filter. J Extra Corpor Technol. 2014;46:229–238.
Stanzel R, Henderson M. An in vitro evaluation of gaseous microemboli handling by contemporary venous reservoirs and oxygenator systems using EDAC. Perfusion. 2016, Vol. 31(1) 38–44.
Meyers G. Understanding off-label use and reference blood flows in modern membrane oxygenators. J Extra Corpor Technol. 2014;49:93–97.
Venema L, Sharma A, Simons A, Bekers O, Weerwind P. Contemporary oxygenator design relative to hemolysis. J Extra Corpor Technol. 2014;46:212–216.
Schweiger M, Dave H, Kelly J, Hubler M. Strategic and operational aspects of a transfusion-free neonatal arterial switch operation. Interact Cardiovasc Thorac Surg. 2013;16: 890–891.
Wypij D, Jonas R, Bellinger D, Del Nido P, Mayer J, Bacha E, Forbess J, Pigula F, Laussen P, Newburger J. The effect of hematocrit during hypothermic cardiopulmonary bypass in infant heart surgery: results from the combined Boston hematocrit trials. J. Thorac & Cardiovasc Surg. 2007;135:355–360
Bronson S, Riley J, Blessing J, Ereth M, Dearani J. Prescriptive patient extracorporeal circuit and oxygenator sizing reduces hemodilution and allogeneic blood product transfusion during adult cardiac surgery. J Extra Corpor Technol. 2013;45:167–172.
Naik S, Knight A, Elliott M. A successful modification of ultrafiltration for cardiopulmonary bypass in children. Perfusion. 1991; 6:41–50.
Thapmongkol S, Masaratana P, Subtaweesin T, Sayasathid J, Thatsakorn K, Namchaisiri J. The effects of modified ultrafiltration on clinical outcomes of adult and pediatric cardiac surgery. Asian Biomedicine. 2015;9:591–599.
Valleley MS, Buckley KW, Hayes KM, Fortuna RR, Geiss DM, Holt DW. Are there benefits to a fresh whole blood vs. packed red blood cell cardiopulmonary bypass prime on outcomes in neonatal and pediatric cardiac surgery? J Extra Corpor Technol. 2007;39:168–176.
Bianchi P, Cotza M, Beccaris C, Silvetti S, Isgro G, Pome G, Giamberti A, Ranucci M, For the Surgical and Clinical Outcome Researcg (SCORE) Group. Early or late fresh frozen plasma administration in newborns and small infants undergoing cardiac surgery: the APPEAR randomized trial. British J Anes. 2017;118(5):788–796
Vohra HA, Adluri K, Willets R, Horsburgh A, Barron DJ, Brawn WJ. Changes in potassium concentration and haematocrit associated with cardiopulmonary bypass in paediatric cardiac surgery. Perfusion. 2007;22:92.
Golab HD, Takkenberg JJ, van Gerner-Weelink GL, et al. Effects of cardiopulmonary bypass circuit reduction and residual volume salvage on allogeneic transfusion requirements in infants undergoing cardiac surgery. Interact Cardiovasc Thorac Surg. 2007;6:335–339.
Mou SS, Giroir BP, Molitor-Kirsch EA, et al. Fresh whole blood versus reconstituted blood for pump priming in heart surgery in infants. N Engl J Med. 2004;351:1635–1644.
Schroth M, Plank C, Meibner U, et al. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery. Pediatrics. 2006;118:e76–e84.
Alkan T, Akçevin A, Undar A, Türkoglu H, Paker T, Aytaç A. Pulsatile perfusion during cardiopulmonary bypass procedures in neonates, infants, and small children. ASAIO J. 2007;53:706–709.
Guzzetta NA, Miller BE, Todd K, et al. Clinical measures of heparin’s effect and thrombin inhibitor levels in pediatric patients with congenital heart disease. Anesth Analg. 2006;103:1131–1138.
Owings JT, Pollock ME, Gosselin RC, Ireland K, Jahr JS, Larkin EC. Anticoagulation of children undergoing cardiopulmonary bypass is overestimated by current monitoring techniques. Arch Surg. 2000;135:1042–1047.
Polito A, Ricci Z, Di Chiara L, et al. Cerebral blood flow during cardiopulmonary bypass in pediatric cardiac surgery: the role of transcranial Doppler - a systematic review of the literature. Cardiovasc Ultrasound. 2006;4:47.
Chan KL, Summerhayes RG, Ignjatovic V, Horton SB, Monagle PT. Reference values for kaolin-activated thromboelastography in healthy children. Anesthesia and Analgesia. 2007;105:1610–1613.
Williams GD, Ramamoorthy C. Brain monitoring and protection during pediatric cardiac surgery. Semin Cardiothorac Vasc Anesth. 2007;11:23.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Manrique, A.M., Vargas, D.P., Palmer, D., Kelly, K., Litchenstein, S.E. (2020). The Effects of Cardiopulmonary Bypass Following Pediatric Cardiac Surgery. In: Munoz, R., Morell, V., da Cruz, E., Vetterly, C., da Silva, J. (eds) Critical Care of Children with Heart Disease . Springer, Cham. https://doi.org/10.1007/978-3-030-21870-6_10
Download citation
DOI: https://doi.org/10.1007/978-3-030-21870-6_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-21869-0
Online ISBN: 978-3-030-21870-6
eBook Packages: MedicineMedicine (R0)